Data protection Impressum

Life sciences

CHUV has opened a new ambulatory radiology facility in Lausanne to centralize imaging services and modernize its diagnostic infrastructure.

CHUV opens new ambulatory radiology facility to improve patient access and diagnostic capacity

25 November 2025

Distalmotion has raised USD 150 million in Series G financing to accelerate the U.S. expansion of its DEXTER surgical robot.

Distalmotion raises USD 150 million to scale its DEXTER surgical robot in the United States

19 November 2025

LEM Surgical has completed its first U.S. clinical procedures using the Dynamis Robotic Surgical System.

Bern’s LEM Surgical completes first U.S. clinical procedures with its Dynamis robotic system

19 November 2025

A Swiss-led research consortium is developing an AI-powered microfactory capable of producing patient-specific tumor models to revolutionize precision oncology.

ORION: A smart microfactory to accelerate personalized cancer treatments

10 November 2025

The Munich- and Lausanne-based biotech secures Europe’s largest-ever Series C financing to accelerate development of next-generation antibody-drug conjugates.

Tubulis raises EUR 308 million to advance ADC therapies and expand its clinical pipeline

29 October 2025

Neurotechnology company ONWARD Medical extends its cash runway through 2026 and prepares to expand commercialization and clinical development of its ARC Therapy systems.

ONWARD Medical raises over EUR 50 million to advance spinal cord therapies

27 October 2025

Adaptyv raises USD 8 million to accelerate AI-powered protein validation

27 October 2025

Vaud-based FemTech company Aspivix begins commercial rollout in Southern California and New York following strong clinical validation and growing U.S. demand.

Aspivix launches its breakthrough Carevix device in the United States

21 October 2025

Lausanne-based biotech ADC Therapeutics has secured USD 60 million in new financing to expand commercialization of its cancer treatment ZYNLONTA.

ADC Therapeutics raises USD 60 million to strengthen oncology portfolio

21 October 2025

EssilorLuxottica’s acquisition of RetinAI strengthens its medtech portfolio with advanced AI and data-driven solutions for eye disease management.

EssilorLuxottica acquires Bern-based RetinAI to accelerate AI-powered eye health innovation

20 October 2025

1 2 3 4 5 … 45